Immunogenic fraction active against bilharzioses, its preparatio

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 858, 424 86, 424 87, 530395, 435 722, 435810, 435975, 436548, 514 8, 514 9, 514 21, A61K 3702, A61K 3900, A61K 39395, C04K 1514

Patent

active

050215604

ABSTRACT:
The present invention relates to an immunogenic fraction active against bilharzioses. This glycoprotein extracted from hemocyanin of a mollusc, is characterized in that its glucidic fraction represents 5 to 25% of the glycoprotein molecule and in that the molar composition of said glucidic fraction (calculated on the basis of 3 mannose residues) is substantially the following:

REFERENCES:
patent: 4384992 (1983-05-01), Capron et al.
Annales de L'Institut Pasteur, A. Capron et al., "Les Antigenes de Schistma Mansoni", Nov. 1965, vol. 109, pp. 798-810.
Nature, J. M. Grzych et al., "An Anti-Idiotype Vaccine Against Experimental Schistosomiasis", 4 Jul. 1985, vol. 316, pp. 74-76.
Chemical Abstracts, Brenowitz et al., "Immunochemical Relationships and Subunit Composition of Molluskan Hemocyanin", vol. 106, 1987, abstract 115428V.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Immunogenic fraction active against bilharzioses, its preparatio does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunogenic fraction active against bilharzioses, its preparatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic fraction active against bilharzioses, its preparatio will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1027758

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.